with flutamide has a syn-ergistic action in inhibiting the proliferation of LNCaP.

The relationship of erectile dysfunction (ED) with serum levels of total testosterone (TT) and free testosterone (FT) was investigated in 53 men with type 2 diabetes under 50 years of age.The relevant clinical status was matched and no significant difference was noticed for TT [ ( 14.11 ±5.81 vs 14.97 ±4.93 ) nmol/L] and FT [ (9.31 ± 8.84 vs 8.72 ± 5.33 ) pg/ml ] levels in type 2 diabetic patients with and without ED.This study has demonstrated that testicular androgen may not contribute to ED in young and middle-aged men with type 2 diabetes.

External counterpulsation （ECP） technology represents a non-invasive adjunctive circulation treatment approach implemented in clinical practice since 1962， initially focused on managing cardio-cerebrovascular diseases. Over the past four decades， continuous research and advancements in medical technology have facilitated the evolution of enhanced external counterpulsation （EECP）. This therapeutic modality can enhance the function of vascular endothelial cells， promote blood circulation， and improve metabolism by increasing organ perfusion pressure and blood flow. Given its demonstrated safety， efficacy， and cost-effectiveness， EECP has not only played a significant role in the clinical treatment of cardio-cerebrovascular diseases but also expanded into diverse domains， including andrology， which provides new therapeutic avenues for various health concerns. Particularly in the treatment of male erectile dysfunction （ED）， EECP has shown remarkable potential， and certain clinical practice experience and scientific research results are accumulated. Research indicates that the occurrence of ED is closely associated with endothelial dysfunction and microcirculatory issues. EECP has been shown to effectively alleviate symptoms in ED patients and improve treatment outcomes by optimizing endothelial function and overall systemic health.This article reviews relevant findings from both domestic and international sources， summarizing the current research on the application of EECP in treating andrological diseases. It focuses on analyzing its clinical effects and mechanisms in treating ED and explores potential applications in other male urological conditions. Additionally， this paper discusses the limitations of current research and offers insights into future research directions to provide a more robust scientific basis and references for the use of EECP in managing andrological diseases.